40th ECDD meeting in Geneva: pivotal moment for global Cannabis policies.

This week in Geneva for the first time ever, the WHO drugs committee has heard the voices of doctors, patients, and researchers, and started to weigh the harms and benefits of Cannabis neutrally.

Press release: WHO & Cannabis – 40th ECDD meeting

PRESS RELEASE • Cannabis policy reform: Activists from all continents converge in Geneva – Historical day inside of the World Health Organization.

Human Rights violations in the name of Drug Control: contribution to UN Human Rights

57 years of Global and Systematic Human Rights violations in the name of #DrugControl: Right to a Remedy and Reparation for Victims of Gross Violations of International Human Rights Law.

[VIDEO] Hepatitis C among people who use drugs, Governments & the UN.

FAAAT co-hosted, last March at the United Nations, a consensus conference where governments and representative of drug users discussed the global state of Hepatitis C and recommendations raised from the practice. Video and track record.

Crimson paper #3. The review(s).

Pre & Critical reviews: insights into the processes of the WHO scientific abuse liability assessment for drugs.

Cannabis review by the WHO: all you need to know

In 2018 for the first time, the World Health Organization is assessing the medical uses and harms of Cannabis, and will recommend the suitable classification to be applied internationally. We promote an objective and independent assessment, that recognizes and acknowledges modern research on Cannabis. Support us!

Pin It on Pinterest